LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-79 Cr | ₹-57 Cr | ₹-37 Cr | ₹-78 Cr | ₹-64 Cr |
What is the latest Cash Flow from Investing Activities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-79 Cr |
| Mar2024 | ₹-57 Cr |
| Mar2023 | ₹-37 Cr |
| Mar2022 | ₹-78 Cr |
| Mar2021 | ₹-64 Cr |
How is Cash Flow from Investing Activities of LINCOLN PHARMACEUTICALS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-79 Cr | Negative | |
| Mar2024 | ₹-57 Cr | Negative | |
| Mar2023 | ₹-37 Cr | Negative | |
| Mar2022 | ₹-78 Cr | Negative | |
| Mar2021 | ₹-64 Cr | - | |
Compare Cash Flow from Investing Activities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,185.6 Cr | 7% | -4.2% | 7.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 7% |
-4.2% |
7.5% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses